文献速递胃肠外科围术期管理与 ERAS

结直肠癌围手术期炎症标志物纵向变化及术后复测获益

A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement.
PubMed 文献 · Ann Surg · 2018-01-01

该回顾性多中心研究纳入1998至2012年6家医院2280例结直肠癌手术患者,刻画围手术期中性粒细胞淋巴细胞比(NLR)与淋巴细胞单核细胞比(LMR)的纵向轨迹,并在587例有完整术前及术后21至56天数据的患者中分析标志物「转化」与生存的关系。多因素Cox回归显示NLR变化组与LMR变化组均与总生存独立相关(均P < 0.001),术前术后均低炎症状态者生存最佳。

要点

  • 围手术期NLR与LMR轨迹明确,术后21至56天为理想复测窗口。
  • NLR变化组与LMR变化组均与总生存独立相关(均P < 0.001)。
  • 术前术后均低炎症状态者生存最佳,炎症状态转化与生存差异相关。

核心结论

  • 结直肠癌围手术期全身炎症反应轨迹可被刻画,术后21至56天复测NLR与LMR有助于进一步预后判断。

研究设计与样本

  • 回顾性多中心研究,收集1998年1月至2012年12月6家医院数据,纳入2280例完整数据患者。
  • 转化亚组分析纳入587例具备术前及术后21至56天完整数据的患者。
  • 采用多因素Cox回归模型分析转化分组与生存的关系。

主要发现

  • 围手术期NLR与LMR纵向轨迹清晰,确定术后21至56天为理想复测期。
  • 多因素分析中NLR变化组(P < 0.001)与LMR变化组(P < 0.001)均与总生存独立相关。
  • 两种标志物均显示术前与术后均低炎症状态者生存最佳。
  • 术前至术后炎症状态的变化与生存差异相关。

临床怎么用

  • 结直肠癌患者术后21至56天可复测NLR与LMR以辅助预后分层。
  • 解读炎症标志物时应结合术前与术后动态变化,而非仅看单次术前值。

局限性

  • 研究为回顾性设计。
  • 转化亚组仅587例具备完整术前与术后数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize the longitudinal course of the systemic inflammatory response (SIR) throughout the perioperative period. To investigate whether postoperative changes in the neutrophil-to-lymphocyte ratio (NLR) or lymphocyte-to-monocyte ratio (LMR) when compared with preoperative levels ('conversion') are associated with survival differences in colorectal cancer patients undergoing resection. BACKGROUND: Recent evidence suggests that preoperative measurements of markers of the SIR including the NLR and LMR are prognostic. However, a few data exist evaluating longitudinal changes in the SIR especially in regards to their association with surgical interventions, optimal timing of assessment, and their effect on patient survival. METHODS: Data from 6 hospitals from January 1998 to December 2012 were retrospectively collected. We examined 2280 patients with complete data. For the subgroup analysis investigating conversion, we examined 587 patients with full preoperative and postoperative data from 21 to 56 days postoperative. Patients were stratified into 4 groups for analysis of conversion in a multivariate Cox-regression model. RESULTS: A longitudinal profile for the perioperative NLR and LMR was clearly characterized identifying an optimal period of remeasurement at 21 to 56 days postoperation. In multivariate analysis both NLR change group (P < 0.001) and LMR change group (P < 0.001) were independently associated with overall survival. For both biomarkers, patients with both a low preoperative and postoperative inflammatory state had the best survival. A change from the preoperative to postoperative inflammatory state was associated with a survival difference. CONCLUSIONS: This study characterizes the perioperative SIR profile and provides evidence for the remeasurement of SIR biomarkers postoperatively at 21 to 56 days for further prognostication.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Chan JCY, Diakos CI, Chan DLH, et al. A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement. Ann Surg. 2018. PMID: 28394869. doi:10.1097/SLA.0000000000002251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。